Hart A

No ORCID on file · 5 papers in corpus · active 2008-2024

Study types

  • article 2

Condition tags

  • endometriosis 2
  • dysmenorrhea 1
2024
EFSA journal. European Food Safety Authority ·doi:10.2903/j.efsa.2024.8497

The European Commission asked EFSA to update its 2011 risk assessment on polybrominated diphenyl ethers (PBDEs) in food, focusing on 10 congeners: BDE-28, -47, -49, -99, -100, -138, -153, -154, -183 and ‑209. The CONTAM Panel concluded that…

2023
EFSA journal. European Food Safety Authority ·doi:10.2903/j.efsa.2023.6857

In 2015, EFSA established a temporary tolerable daily intake (t-TDI) for BPA of 4 μg/kg body weight (bw) per day. In 2016, the European Commission mandated EFSA to re-evaluate the risks to public health from the presence of BPA in foodstuff…

2022
Frontiers in pain research (Lausanne, Switzerland) ·doi:10.3389/fpain.2022.1053026

BackgroundDysmenorrhea is suggested to increase the risk of chronic pain by enhancing central sensitization. However, little is known about whether emotional and cognitive responses induced by dysmenorrhea contribute to chronic pain interfe…

article 2011
Human Reproduction ·doi:10.1093/humrep/der412

BACKGROUND: Endometriosis is a metastatic disease without obvious tumorigenesis. Expression of S100P, S100A4, osteopontin (OPN) or anterior gradient homologue 2 (AGR2) proteins can induce metastasis but fail to induce tumorigenesis per se. …

article 2008
Human Reproduction ·doi:10.1093/humrep/den416

BACKGROUND: To test our hypothesis that eutopic secretory phase endometrium from women with endometriosis is similar to proliferative phase endometrium from fertile women without endometriosis, we explored the expression of regulators of ce…